247 related articles for article (PubMed ID: 21885812)
21. Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis.
Janakiram NB; Mohammed A; Bryant T; Lightfoot S; Collin PD; Steele VE; Rao CV
Cancer Prev Res (Phila); 2015 Apr; 8(4):327-37. PubMed ID: 25657017
[TBL] [Abstract][Full Text] [Related]
22. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
[TBL] [Abstract][Full Text] [Related]
24. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity.
Benbrook DM; Guruswamy S; Wang Y; Sun Z; Mohammed A; Zhang Y; Li Q; Rao CV
Cancer Prev Res (Phila); 2013 Sep; 6(9):908-16. PubMed ID: 23852423
[TBL] [Abstract][Full Text] [Related]
26. Licofelone inhibits interleukin-18-induced pro-inflammatory cytokine release and cellular proliferation in human mesangial cells.
Wu YJ; Xue M; Chen H
Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):166-72. PubMed ID: 22433003
[TBL] [Abstract][Full Text] [Related]
27. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ
J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935
[TBL] [Abstract][Full Text] [Related]
28. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases.
Pelletier JP; Boileau C; Boily M; Brunet J; Mineau F; Geng C; Reboul P; Laufer S; Lajeunesse D; Martel-Pelletier J
Arthritis Res Ther; 2005; 7(5):R1091-102. PubMed ID: 16207326
[TBL] [Abstract][Full Text] [Related]
29. Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.
Alvaro-Gracia JM
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i21-5. PubMed ID: 14752172
[TBL] [Abstract][Full Text] [Related]
30. Chemopreventive effect of ERĪ²-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice.
Giroux V; Bernatchez G; Carrier JC
Mol Carcinog; 2011 May; 50(5):359-69. PubMed ID: 21480389
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma.
Rao CV; Janakiram NB; Madka V; Devarkonda V; Brewer M; Biddick L; Lightfoot S; Steele VE; Mohammed A
Oncotarget; 2015 Oct; 6(32):33290-305. PubMed ID: 26429877
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ
PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006
[TBL] [Abstract][Full Text] [Related]
33. Licofelone, a dual cyclooxygenase/5-lipoxygenase inhibitor, reverses endotoxin-induced impaired atrial chronotropic responsiveness to cholinergic stimulation in rats.
Nikoui V; Mehrzadi S; Khan MI; Aman W; Ostadhadi S; Dehpour AR
Eur J Pharmacol; 2020 Nov; 887():173569. PubMed ID: 32949599
[TBL] [Abstract][Full Text] [Related]
34. Chemoprevention of colon cancer by Korean food plant components.
Kim DJ; Shin DH; Ahn B; Kang JS; Nam KT; Park CB; Kim CK; Hong JT; Kim YB; Yun YW; Jang DD; Yang KH
Mutat Res; 2003; 523-524():99-107. PubMed ID: 12628507
[TBL] [Abstract][Full Text] [Related]
35. Modulation of smoke-induced DNA and microRNA alterations in mouse lung by licofelone, a triple COX-1, COX-2 and 5-LOX inhibitor.
Izzotti A; Balansky R; Micale RT; Pulliero A; La Maestra S; De Flora S
Carcinogenesis; 2020 Mar; 41(1):91-99. PubMed ID: 31562745
[TBL] [Abstract][Full Text] [Related]
36. Effects of dietary flaxseed on intestinal tumorigenesis in Apc(Min) mouse.
Bommareddy A; Zhang X; Schrader D; Kaushik RS; Zeman D; Matthees DP; Dwivedi C
Nutr Cancer; 2009; 61(2):276-83. PubMed ID: 19235044
[TBL] [Abstract][Full Text] [Related]
37. Dietary feeding of grape seed extract prevents intestinal tumorigenesis in APCmin/+ mice.
Velmurugan B; Singh RP; Kaul N; Agarwal R; Agarwal C
Neoplasia; 2010 Jan; 12(1):95-102. PubMed ID: 20072658
[TBL] [Abstract][Full Text] [Related]
38. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in Apc
Saxena A; Tammali R; Ramana KV; Srivastava SK
Curr Cancer Drug Targets; 2018; 18(9):905-911. PubMed ID: 28786349
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice.
Kumar G; Patlolla JM; Madka V; Mohammed A; Li Q; Zhang Y; Biddick L; Singh A; Gillaspy A; Lightfoot S; Steele VE; Kopelovich L; Rao CV
Am J Cancer Res; 2016; 6(5):894-909. PubMed ID: 27293987
[TBL] [Abstract][Full Text] [Related]
40. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial.
Bias P; Buchner A; Klesser B; Laufer S
Am J Gastroenterol; 2004 Apr; 99(4):611-8. PubMed ID: 15089890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
